APA (7th ed.) Citation

Mayer, B. T., Zhang, L., deCamp, A. C., Yu, C., Sato, A., Angier, H., . . . Gelderblom, H. C. (2024). Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV. Pharmaceutics, 16(5), 594. https://doi.org/10.3390/pharmaceutics16050594

Chicago Style (17th ed.) Citation

Mayer, Bryan T., et al. "Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People Without HIV." Pharmaceutics 16, no. 5 (2024): 594. https://doi.org/10.3390/pharmaceutics16050594.

MLA (9th ed.) Citation

Mayer, Bryan T., et al. "Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People Without HIV." Pharmaceutics, vol. 16, no. 5, 2024, p. 594, https://doi.org/10.3390/pharmaceutics16050594.